Home › Bronchial Cancer › North Carolina
Bronchial Cancer clinical trials in North Carolina
3 studies for Bronchial Cancer are looking for participants at sites in North Carolina.
Cities in North Carolina
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of North Carolina Medical Center, Chapel Hill
- Duke Cancer Institute, Durham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- University of North Carolina, Chapel Hill
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jun 26, 2026 · NCT04614103Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Durham VA Medical Center, Durham, NC, Durham
Recruiting
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT02984761From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.